COMMUNIQUÉS West-GlobeNewswire

ObsEva SA reports additional positive Phase 3 results of IMPLANT 2 trial showing significant increase of Live Birth Rate (LBR) following IVF with Single Embryo Transfer (SET)
03/10/2018
Phase 3 IMPLANT 2 trial results showed Live Birth Rate increased by up to 35% with Nolasiban treatment Nolasiban safety profile not different from placebo in IMPLANT 2 European MAA submission confirmed to be targeted [...]
GW Pharmaceuticals plc Announces Pricing of Public Offering of ADSs Raising Gross Proceeds of $300 Million
03/10/2018
LONDON and CARLSBAD, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, "GW," and the “Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel [...]
Telix Pharmaceuticals and Cardinal Health Enter into Distribution Agreement for Prostate Cancer Imaging
03/10/2018
INDIANAPOLIS and COLUMBUS, Ohio, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals (US) Inc. (“Telix USA”), a subsidiary of Telix Pharmaceuticals Limited (ASX:TLX), a clinical-stage biopharmaceutical company [...]
Pain Therapeutics Announces Investor Call to Provide Strategic Update
03/10/2018
Call to be Held on Thursday, October 4th, 10:00 AM Eastern Time AUSTIN, Texas, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical company, today announced that it will host a [...]
Dr. Brian Buinewicz Introduces EMSCULPT® to the Long Island Area
03/10/2018
Now, patients can simultaneously build muscle and burn fat for outstanding cosmetic results DOYLESTOWN, Pa., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Dr. Brian Buinewicz of Buinewicz Plastic Surgery has been offering patients [...]
Paratek Announces FDA Approval of NUZYRA™ (Omadacycline)
03/10/2018
– Modernized Tetracycline for the Treatment of Community-Acquired Bacterial Pneumonia (CABP) and Acute Skin and Skin Structure Infections (ABSSSI) specifically designed to overcome tetracycline resistance – – First and [...]
Genesis HealthCare Announces Completed Divestiture of 16 Facilities in Texas
03/10/2018
KENNETT SQUARE, Pa., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (Genesis, or the Company) (NYSE: GEN), one of the largest post-acute care providers in the United States, today announced it completed the sale [...]
Osiris Therapeutics, Inc. Announces Peer-Reviewed Publication Demonstrating That Lyopreservation Method Developed for Living Tissues is an Alternative to Cryopreservation with the Convenience of Ambient Storage
02/10/2018
COLUMBIA, Md., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, [...]
GenMark Diagnostics Announces FDA Submission of its ePlex Blood Culture Identification Gram-Negative and ePlex Blood Culture Identification Fungal Pathogen Panels
02/10/2018
Submissions Now Complete for All Three ePlex Molecular Multiplex Panels Designed for the Diagnosis and Management of Bloodstream Infections That Can Lead to Sepsis CARLSBAD, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) -- [...]
Nightstar Announces Closing of Public Offering and Full Exercise of Underwriters’ Option
02/10/2018
WALTHAM, Mass. and LONDON, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Nightstar Therapeutics plc (NASDAQ:NITE), a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, today announced the [...]
Conatus Pharmaceuticals Announces Three Accepted Abstracts for AASLD Annual Meeting
02/10/2018
SAN DIEGO, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) announced today that two abstracts – one addressing clinical results with the company’s pan-caspase inhibitor, emricasan, and one [...]
Novavax to Highlight RSV Program Data at Two Upcoming Meetings
02/10/2018
GAITHERSBURG, Md., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX) today announced that its representatives will share data from its RSV F vaccine program via oral and poster presentations at IDWeek 2018 [...]
SELLAS to Present Data from Phase 2b Trial of NeuVax + Herceptin® at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting
02/10/2018
NEW YORK, Oct. 02, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq:SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer [...]
Cytokinetics to Host R&D Day on October 16, 2018
02/10/2018
SOUTH SAN FRANCISCO, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK), today announced that it will host an R&D Day on Tuesday, October 16, 2018 from 8:30 AM to 12:30 PM ET at the [...]
GENFIT: New data to be presented at 2018 AASLD meeting, ahead of key results expected in 2018 and 2019
02/10/2018
GENFIT: New data to be presented at 2018 AASLD meeting, ahead of key results expected in 2018 and 2019 KOL event to be held ahead of expected data release with elafibranor in PBC by end of 2018 (Phase 2) and in NASH end [...]
GENFIT : Nouvelles données présentées lors du congrès de l'AASLD 2018, en amont de résultats clés attendus en 2018 et 2019
02/10/2018
GENFIT : Nouvelles données présentées lors du congrès de l'AASLD 2018, en amont de résultats clés attendus en 2018 et 2019 KOL event organisé en amont de la publication des résultats d'elafibranor attendus fin 2018 dans [...]
Halo Labs, Experienced Manufacturers of Cannabis Oils & Concentrates, Prepares to Go Public -- CFN Media
02/10/2018
SEATTLE, WA, Oct. 02, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication [...]
Mesa Labs Declares Quarterly Dividend
02/10/2018
Lakewood, Colo., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0 [...]
CORRECTING and REPLACING – SeaSpine Announces Preliminary Results for Third Quarter 2018
02/10/2018
Increases 2018 Financial Outlook CARLSBAD, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by SeaSpine Holdings Corporation (NASDAQ: SPNE) please note that in the [...]

Pages